137 related articles for article (PubMed ID: 11323006)
1. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues.
Kamp P; Strathmann A; Ragg H
Thromb Res; 2001 Mar; 101(6):483-91. PubMed ID: 11323006
[TBL] [Abstract][Full Text] [Related]
2. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
Myles T; Church FC; Whinna HC; Monard D; Stone SR
J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
[TBL] [Abstract][Full Text] [Related]
3. Heparin cofactor II is regulated allosterically and not primarily by template effects. Studies with mutant thrombins and glycosaminoglycans.
Sheehan JP; Tollefsen DM; Sadler JE
J Biol Chem; 1994 Dec; 269(52):32747-51. PubMed ID: 7806495
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of heparin cofactor II anticoagulant activity.
Bauman SJ; Church FC
J Biol Chem; 1999 Dec; 274(49):34556-65. PubMed ID: 10574918
[TBL] [Abstract][Full Text] [Related]
5. Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha 1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein.
Kounnas MZ; Church FC; Argraves WS; Strickland DK
J Biol Chem; 1996 Mar; 271(11):6523-9. PubMed ID: 8626456
[TBL] [Abstract][Full Text] [Related]
6. Role of the proposed serpin-enzyme complex receptor recognition site in binding and internalization of thrombin-heparin cofactor II complexes by hepatocytes.
Maekawa H; Tollefsen DM
J Biol Chem; 1996 Aug; 271(31):18604-9. PubMed ID: 8702511
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation.
Noda A; Wada H; Kusiya F; Sakakura M; Onishi K; Nakatani K; Gabazza EC; Asahara N; Tsukada M; Nobori T; Shiku H
Clin Appl Thromb Hemost; 2002 Jul; 8(3):265-71. PubMed ID: 12361205
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-inhibitor complexes in the blood during and after delivery.
Andersson T; Lorentzen B; Hogdahl H; Clausen T; Mowinckel MC; Abildgaard U
Thromb Res; 1996 Apr; 82(2):109-17. PubMed ID: 9163064
[TBL] [Abstract][Full Text] [Related]
9. Comparative metabolism and distribution of rabbit heparin cofactor II and rabbit antithrombin in rabbits.
Hatton MW; Hoogendoorn H; Southward SM; Ross B; Blajchman MA
Am J Physiol; 1997 May; 272(5 Pt 1):E824-31. PubMed ID: 9176182
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a novel isoform of heparin cofactor II in human liver.
Bano S; Fatima S; Ahamad S; Ansari S; Gupta D; Tabish M; Rehman SU; Jairajpuri MA
IUBMB Life; 2020 Oct; 72(10):2180-2193. PubMed ID: 32827448
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans.
Van Deerlin VM; Tollefsen DM
J Biol Chem; 1991 Oct; 266(30):20223-31. PubMed ID: 1939083
[TBL] [Abstract][Full Text] [Related]
12. Localization of heparin cofactor II in injured human skin: a potential role in wound healing.
Hoffman M; Loh KL; Bond VK; Palmieri D; Ryan JL; Church FC
Exp Mol Pathol; 2003 Oct; 75(2):109-18. PubMed ID: 14516771
[TBL] [Abstract][Full Text] [Related]
13. The role of heparin cofactor II in the modulation of hemostasis.
Salem HH; Thompson EA
Dev Biol Stand; 1987; 67():67-72. PubMed ID: 3301469
[TBL] [Abstract][Full Text] [Related]
14. Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
McGuire EA; Tollefsen DM
J Biol Chem; 1987 Jan; 262(1):169-75. PubMed ID: 3793724
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.
Verhamme IM
Anal Biochem; 2012 Feb; 421(2):489-98. PubMed ID: 22206940
[TBL] [Abstract][Full Text] [Related]
16. Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex.
Maekawa H; Sato H; Tollefsen DM
Thromb Res; 2000 Dec; 100(5):443-51. PubMed ID: 11150588
[TBL] [Abstract][Full Text] [Related]
17. Ligand binding to thrombin exosite II induces dissociation of the thrombin-heparin cofactor II(L444R) complex.
Han JH; Tollefsen DM
Biochemistry; 1998 Mar; 37(9):3203-9. PubMed ID: 9485475
[TBL] [Abstract][Full Text] [Related]
18. The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand.
Boyle AJ; Roddick LA; Bhakta V; Lambourne MD; Junop MS; Liaw PC; Weitz JI; Sheffield WP
BMC Biochem; 2013 Mar; 14():6. PubMed ID: 23496873
[TBL] [Abstract][Full Text] [Related]
19. Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibition.
Ciaccia AV; Monroe DM; Church FC
J Biol Chem; 1997 May; 272(22):14074-9. PubMed ID: 9162031
[TBL] [Abstract][Full Text] [Related]
20. Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
Thromb Haemost; 2005 Oct; 94(4):808-13. PubMed ID: 16270635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
